Published in Int Anesthesiol Clin on January 01, 2016
Autonomic nerve development contributes to prostate cancer progression. Science (2013) 6.11
Can anesthetic technique for primary breast cancer surgery affect recurrence or metastasis? Anesthesiology (2006) 5.19
Gene expression profiles of primary breast tumors maintained in distant metastases. Proc Natl Acad Sci U S A (2003) 4.47
Morphine stimulates angiogenesis by activating proangiogenic and survival-promoting signaling and promotes breast tumor growth. Cancer Res (2002) 2.45
Role of prostaglandin E2-dependent angiogenic switch in cyclooxygenase 2-induced breast cancer progression. Proc Natl Acad Sci U S A (2003) 2.23
Cyclooxygenase-2 inhibition by celecoxib reduces proliferation and induces apoptosis in angiogenic endothelial cells in vivo. Cancer Res (2002) 2.09
Mast cell activation contributes to sickle cell pathobiology and pain in mice. Blood (2013) 1.94
Development of peripheral opioid antagonists' new insights into opioid effects. Mayo Clin Proc (2008) 1.87
Anesthetic technique and the cytokine and matrix metalloproteinase response to primary breast cancer surgery. Reg Anesth Pain Med (2010) 1.67
Endogenous nitric oxide enhances prostaglandin production in a model of renal inflammation. J Clin Invest (1994) 1.59
Evidence that postoperative pain is a mediator of the tumor-promoting effects of surgery in rats. Pain (2001) 1.51
Molecular mechanisms of opioid receptor-dependent signaling and behavior. Anesthesiology (2011) 1.50
Methylnaltrexone inhibits opiate and VEGF-induced angiogenesis: role of receptor transactivation. Microvasc Res (2006) 1.48
The novel role of the mu opioid receptor in lung cancer progression: a laboratory investigation. Anesth Analg (2010) 1.46
Substance P stimulates neovascularization in vivo and proliferation of cultured endothelial cells. Microvasc Res (1990) 1.45
COX-2 inhibitor celecoxib prevents chronic morphine-induced promotion of angiogenesis, tumour growth, metastasis and mortality, without compromising analgesia. Br J Cancer (2007) 1.40
Simultaneous inhibition of the receptor kinase activity of vascular endothelial, fibroblast, and platelet-derived growth factors suppresses tumor growth and enhances tumor radiation response. Cancer Res (2002) 1.40
Opioids as modulators of cell death and survival--unraveling mechanisms and revealing new indications. Pharmacol Rev (2004) 1.40
Management of cancer pain: ESMO Clinical Practice Guidelines. Ann Oncol (2011) 1.39
Pattern and quality of care of cancer pain management. Results from the Cancer Pain Outcome Research Study Group. Br J Cancer (2009) 1.37
Neurobiology of substance P and the NK1 receptor. J Clin Psychiatry (2002) 1.35
The activity of guanine exchange factor NET1 is essential for transforming growth factor-beta-mediated stress fiber formation. J Biol Chem (2001) 1.31
Interaction of morphine, fentanyl, sufentanil, alfentanil, and loperamide with the efflux drug transporter P-glycoprotein. Anesthesiology (2002) 1.28
Attenuation of vascular permeability by methylnaltrexone: role of mOP-R and S1P3 transactivation. Am J Respir Cell Mol Biol (2007) 1.27
Morphine attenuates surgery-induced enhancement of metastatic colonization in rats. Pain (1993) 1.16
Mast cells, angiogenesis, and tumour growth. Biochim Biophys Acta (2010) 1.15
Vascular hyperpermeability, angiogenesis, and stroma generation. Cold Spring Harb Perspect Med (2012) 1.15
Morphine suppresses tumor angiogenesis through a HIF-1alpha/p38MAPK pathway. Am J Pathol (2010) 1.11
Morphine stimulates vascular endothelial growth factor-like signaling in mouse retinal endothelial cells. Curr Neurovasc Res (2006) 1.10
Morphine-induced epidermal growth factor pathway activation in non-small cell lung cancer. Anesth Analg (2011) 1.09
Overexpression of the μ-opioid receptor in human non-small cell lung cancer promotes Akt and mTOR activation, tumor growth, and metastasis. Anesthesiology (2012) 1.05
Can regional analgesia reduce the risk of recurrence after breast cancer? Methodology of a multicenter randomized trial. Contemp Clin Trials (2008) 1.02
Imaging delta- and mu-opioid receptors by PET in lung carcinoma patients. J Nucl Med (2007) 1.00
Pharmacokinetics and pharmacodynamics of subcutaneous morphine pellets in the rat. J Pharmacol Exp Ther (1985) 1.00
Morphine induces mesangial cell proliferation and glomerulopathy via kappa-opioid receptors. Am J Physiol Renal Physiol (2008) 0.98
Influence of morphine on pericyte-endothelial interaction: implications for antiangiogenic therapy. J Oncol (2012) 0.98
Abolition of morphine-immunosuppression in mice lacking the mu-opioid receptor gene. Proc Natl Acad Sci U S A (1998) 0.98
Effect of perioperative opioids on cancer recurrence: a hypothesis. Future Oncol (2010) 0.98
Morphine stimulates cancer progression and mast cell activation and impairs survival in transgenic mice with breast cancer. Br J Anaesth (2014) 0.97
Novel opioid antagonists for opioid-induced bowel dysfunction. Expert Opin Investig Drugs (2011) 0.97
Functional expression of mu-opioid receptors in the human colon cancer cell line, HT-29, and their localization in human colon. Dig Dis Sci (2007) 0.97
Oxycodone/Naloxone prolonged-release: a review of its use in the management of chronic pain while counteracting opioid-induced constipation. Drugs (2014) 0.97
Association of increased postoperative opioid administration with non-small-cell lung cancer recurrence: a retrospective analysis. Br J Anaesth (2014) 0.95
The Mu opioid receptor promotes opioid and growth factor-induced proliferation, migration and Epithelial Mesenchymal Transition (EMT) in human lung cancer. PLoS One (2014) 0.95
Synergistic effects of methylnaltrexone with 5-fluorouracil and bevacizumab on inhibition of vascular endothelial growth factor-induced angiogenesis. Mol Cancer Ther (2008) 0.95
Endogenous opiates and behavior: 2014. Peptides (2015) 0.94
Opioid requirement, opioid receptor expression, and clinical outcomes in patients with advanced prostate cancer. Cancer (2013) 0.94
Coexpression of alpha6beta4 integrin and guanine nucleotide exchange factor Net1 identifies node-positive breast cancer patients at high risk for distant metastasis. Cancer Epidemiol Biomarkers Prev (2009) 0.93
Morphine induces expression of platelet-derived growth factor in human brain microvascular endothelial cells: implication for vascular permeability. PLoS One (2011) 0.93
Thoracic paravertebral regional anesthesia improves analgesia after breast cancer surgery: a randomized controlled multicentre clinical trial. Can J Anaesth (2014) 0.92
Substance P autocrine signaling contributes to persistent HER2 activation that drives malignant progression and drug resistance in breast cancer. Cancer Res (2013) 0.92
Direct effect of morphine on breast cancer cell function in vitro: role of the NET1 gene. Br J Anaesth (2011) 0.89
Effect of anesthetic technique on serum vascular endothelial growth factor C and transforming growth factor β in women undergoing anesthesia and surgery for breast cancer. Anesthesiology (2010) 0.88
Opioids induce renal abnormalities in tumor-bearing mice. Nephron Exp Nephrol (2007) 0.88
Naloxegol: a review of its use in patients with opioid-induced constipation. Drugs (2015) 0.88
Increased μ-opioid receptor expression in metastatic lung cancer. Br J Anaesth (2014) 0.87
A mechanism of action for morphine-induced immunosuppression: corticosterone mediates morphine-induced suppression of natural killer cell activity. J Pharmacol Exp Ther (1994) 0.86
Morphine for the treatment of pain in sickle cell disease. ScientificWorldJournal (2015) 0.86
Involvement of substance P and the NK-1 receptor in cancer progression. Peptides (2013) 0.84
Methylnaltrexone potentiates the anti-angiogenic effects of mTOR inhibitors. J Angiogenes Res (2010) 0.84
Association of opioid requirement and cancer pain with survival in advanced non-small cell lung cancer. Br J Anaesth (2014) 0.84
Opioids for cancer pain: the challenge of optimizing treatment. Metabolism (2010) 0.83
A retrospective analysis of the effect of intraoperative opioid dose on cancer recurrence after non-small cell lung cancer resection. Cancer Med (2014) 0.83
Morphine inhibits migration of tumor-infiltrating leukocytes and suppresses angiogenesis associated with tumor growth in mice. Am J Pathol (2014) 0.81
Addition of noradrenaline to intrathecal morphine augments the postoperative suppression of natural killer cell activity. J Anesth (2004) 0.81
Mast Cell-Mediated Mechanisms of Nociception. Int J Mol Sci (2015) 0.80
Peripheral opioid antagonist enhances the effect of anti-tumor drug by blocking a cell growth-suppressive pathway in vivo. PLoS One (2015) 0.78
Naloxegol , a new drug for the treatment of opioid-induced constipation. Expert Opin Pharmacother (2014) 0.78
Opioid-induced constipation in chronic noncancer pain. Curr Opin Endocrinol Diabetes Obes (2016) 0.77
Peripheral μ-opioid receptor mediated inhibition of calcium signaling and action potential-evoked calcium fluorescent transients in primary afferent CGRP nociceptive terminals. Neuropharmacology (2015) 0.77
Morphine, a potential antagonist of cisplatin cytotoxicity, inhibits cisplatin-induced apoptosis and suppression of tumor growth in nasopharyngeal carcinoma xenografts. Sci Rep (2016) 0.76
Regional anesthesia/analgesia and the risk of cancer recurrence and mortality after prostatectomy: a meta-analysis. Pain Manag (2015) 0.76
Management of opioid-induced constipation in pregnancy: a concise review with emphasis on the PAMORAs. J Clin Pharm Ther (2015) 0.75
The genetic basis of early T-cell precursor acute lymphoblastic leukaemia. Nature (2012) 9.89
Beta-lactam antibiotics offer neuroprotection by increasing glutamate transporter expression. Nature (2005) 7.19
Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia. N Engl J Med (2014) 5.37
A novel retinoblastoma therapy from genomic and epigenetic analyses. Nature (2012) 5.02
Novel mutations target distinct subgroups of medulloblastoma. Nature (2012) 4.82
Sickle blood contains tissue factor-positive microparticles derived from endothelial cells and monocytes. Blood (2003) 3.04
Pain-related behaviors and neurochemical alterations in mice expressing sickle hemoglobin: modulation by cannabinoids. Blood (2010) 2.45
Mechanism of ceftriaxone induction of excitatory amino acid transporter-2 expression and glutamate uptake in primary human astrocytes. J Biol Chem (2008) 2.08
Mast cell activation contributes to sickle cell pathobiology and pain in mice. Blood (2013) 1.94
MDA-7 regulates cell growth and radiosensitivity in vitro of primary (non-established) human glioma cells. Cancer Biol Ther (2004) 1.90
MDA-5 is cleaved in poliovirus-infected cells. J Virol (2007) 1.75
Sickle cell pain: a critical reappraisal. Blood (2012) 1.69
Fibrin glue versus N-butyl-2-cyanoacrylate in corneal perforations. Ophthalmology (2003) 1.58
Emergence of imatinib resistance associated with downregulation of c-kit expression in recurrent gastrointestinal stromal tumor (GIST): optimal timing of resection. J Gastrointest Surg (2009) 1.57
How the Avahan HIV prevention program transitioned from the Gates Foundation to the government of India. Health Aff (Millwood) (2013) 1.50
Unique aspects of mda-7/IL-24 antitumor bystander activity: establishing a role for secretion of MDA-7/IL-24 protein by normal cells. Oncogene (2005) 1.49
Caspase-, cathepsin-, and PERK-dependent regulation of MDA-7/IL-24-induced cell killing in primary human glioma cells. Mol Cancer Ther (2008) 1.48
mda-7/IL-24: exploiting cancer's Achilles' heel. Mol Ther (2005) 1.46
Dual cancer-specific targeting strategy cures primary and distant breast carcinomas in nude mice. Proc Natl Acad Sci U S A (2005) 1.41
Positive and negative regulation of EAAT2 by NF-kappaB: a role for N-myc in TNFalpha-controlled repression. EMBO J (2005) 1.36
mda-7/IL-24, novel anticancer cytokine: focus on bystander antitumor, radiosensitization and antiangiogenic properties and overview of the phase I clinical experience (Review). Int J Oncol (2007) 1.34
Autocrine regulation of mda-7/IL-24 mediates cancer-specific apoptosis. Proc Natl Acad Sci U S A (2008) 1.31
Mechanistic aspects of mda-7/IL-24 cancer cell selectivity analysed via a bacterial fusion protein. Oncogene (2004) 1.27
Historical perspective and recent insights into our understanding of the molecular and biochemical basis of the antitumor properties of mda-7/IL-24. Cancer Biol Ther (2009) 1.25
Systemic correction of storage disease in MPS I NOD/SCID mice using the sleeping beauty transposon system. Mol Ther (2009) 1.24
Cloning and characterization of SARI (suppressor of AP-1, regulated by IFN). Proc Natl Acad Sci U S A (2008) 1.22
MDA-7/IL-24 plus radiation enhance survival in animals with intracranial primary human GBM tumors. Cancer Biol Ther (2008) 1.18
Opioids heal ischemic wounds in the rat. Wound Repair Regen (2005) 1.17
The analgesic potential of cannabinoids. J Opioid Manag (2010) 1.16
Direct gene transfer to the CNS prevents emergence of neurologic disease in a murine model of mucopolysaccharidosis type I. Neurobiol Dis (2011) 1.14
Efficacy and safety of CE-224,535, an antagonist of P2X7 receptor, in treatment of patients with rheumatoid arthritis inadequately controlled by methotrexate. J Rheumatol (2012) 1.13
Melanoma differentiation associated gene-7/interleukin-24 (mda-7/IL-24): novel gene therapeutic for metastatic melanoma. Toxicol Appl Pharmacol (2006) 1.12
Regulation of GST-MDA-7 toxicity in human glioblastoma cells by ERBB1, ERK1/2, PI3K, and JNK1-3 pathway signaling. Mol Cancer Ther (2008) 1.11
Morphine stimulates vascular endothelial growth factor-like signaling in mouse retinal endothelial cells. Curr Neurovasc Res (2006) 1.10
Mouse models for studying pain in sickle disease: effects of strain, age, and acuteness. Br J Haematol (2011) 1.09
Morphine-induced epidermal growth factor pathway activation in non-small cell lung cancer. Anesth Analg (2011) 1.09
Day 14 bone marrow biopsy in predicting complete remission and survival in acute myeloid leukemia. Am J Hematol (2008) 1.08
Rapid and complete resolution of chemotherapy-induced thrombotic thrombocytopenic purpura/hemolytic uremic syndrome (TTP/HUS) with rituximab. Cancer Chemother Pharmacol (2010) 1.04
Characterization of an immunodeficient mouse model of mucopolysaccharidosis type I suitable for preclinical testing of human stem cell and gene therapy. Brain Res Bull (2007) 1.04
Social class and all-cause mortality in an urban population of North India. Acta Cardiol (2005) 1.02
Identification of a potent combination of key Plasmodium falciparum merozoite antigens that elicit strain-transcending parasite-neutralizing antibodies. Infect Immun (2012) 1.01
N-glycosylation of MDA-7/IL-24 is dispensable for tumor cell-specific apoptosis and "bystander" antitumor activity. Cancer Res (2006) 1.01
Melanoma differentiation associated gene-7 (mda-7)/IL-24: a 'magic bullet' for cancer therapy? Expert Opin Biol Ther (2007) 1.00
CYP3A4 mediates growth of estrogen receptor-positive breast cancer cells in part by inducing nuclear translocation of phospho-Stat3 through biosynthesis of (±)-14,15-epoxyeicosatrienoic acid (EET). J Biol Chem (2011) 1.00
Sensitization of nociceptive spinal neurons contributes to pain in a transgenic model of sickle cell disease. Pain (2015) 0.98
Morphine induces mesangial cell proliferation and glomerulopathy via kappa-opioid receptors. Am J Physiol Renal Physiol (2008) 0.98
The development of MDA-7/IL-24 as a cancer therapeutic. Pharmacol Ther (2010) 0.98
Influence of morphine on pericyte-endothelial interaction: implications for antiangiogenic therapy. J Oncol (2012) 0.98
Adjuvant chemotherapy for stage III colon cancer in the oldest old: results beyond clinical guidelines. Cancer (2012) 0.97
Metastasis to the eye and orbit from renal cell carcinoma--a report of three cases and review of literature. Surv Ophthalmol (2007) 0.96
NF-kappaB transcription factor p50 critically regulates tissue factor in deep vein thrombosis. J Biol Chem (2008) 0.95
Naloxone acts as an antagonist of estrogen receptor activity in MCF-7 cells. Mol Cancer Ther (2006) 0.95
Endovascular management in abdominal visceral arterial aneurysms: A pictorial essay. World J Radiol (2011) 0.95
Ionizing radiation enhances adenoviral vector expressing mda-7/IL-24-mediated apoptosis in human ovarian cancer. J Cell Physiol (2006) 0.94
Opioid requirement, opioid receptor expression, and clinical outcomes in patients with advanced prostate cancer. Cancer (2013) 0.94
Novel structural analogues of piperine as inhibitors of the NorA efflux pump of Staphylococcus aureus. J Antimicrob Chemother (2008) 0.94
Triple-helical recognition of RNA using 2-aminopyridine-modified PNA at physiologically relevant conditions. Angew Chem Int Ed Engl (2012) 0.94
Ortner's syndrome secondary to aortic aneurysm. Ann Acad Med Singapore (2012) 0.93
Endothelial nitric oxide synthase is dynamically expressed during bone marrow stem cell differentiation into endothelial cells. Am J Physiol Heart Circ Physiol (2007) 0.92
Improved pregnancy outcomes in women exposed to malaria with high antibody levels against Plasmodium falciparum. J Infect Dis (2013) 0.91
MDA-7/IL-24 as a cancer therapeutic: from bench to bedside. Anticancer Drugs (2010) 0.91
Endogenous heparan sulfate and heparin modulate bone morphogenetic protein-4 signaling and activity. Am J Physiol Cell Physiol (2008) 0.90
Anomalous systemic artery to a normal lung: a rare cause of hemoptysis in adults. Oman Med J (2012) 0.90
A thrombospondin structural repeat containing rhoptry protein from Plasmodium falciparum mediates erythrocyte invasion. Cell Microbiol (2013) 0.90
Cytotoxic and apoptotic activities of novel amino analogues of boswellic acids. Bioorg Med Chem Lett (2007) 0.89
"Burned out" testicular seminoma presenting as a primary gastric malignancy. Int J Clin Oncol (2009) 0.89
Combinatorial treatment of non-small-cell lung cancers with gefitinib and Ad.mda-7 enhances apoptosis-induction and reverses resistance to a single therapy. J Cell Physiol (2007) 0.89
Opioids induce renal abnormalities in tumor-bearing mice. Nephron Exp Nephrol (2007) 0.88
Extranasopharyngeal angiofibroma arising from the infratemporal region. Indian J Otolaryngol Head Neck Surg (2006) 0.88
Genome-wide analysis of the heat stress response in Zebu (Sahiwal) cattle. Gene (2013) 0.85
Mechanisms of acute myocardial infarction study (MAMIS). Biomed Pharmacother (2004) 0.85
Ranpirnase (frog RNase) targeted with a humanized, internalizing, anti-Trop-2 antibody has potent cytotoxicity against diverse epithelial cancer cells. Mol Cancer Ther (2010) 0.85
Purification and identification of O-GlcNAc-modified peptides using phosphate-based alkyne CLICK chemistry in combination with titanium dioxide chromatography and mass spectrometry. J Proteome Res (2011) 0.85
Perinephric extramedullary haematopoiesis in primary myelofibrosis. Br J Haematol (2012) 0.84
Morphine induces albuminuria by compromising podocyte integrity. PLoS One (2013) 0.84
Structure-activity relationship (SAR) of parthenin analogues with pro-apoptotic activity: Development of novel anti-cancer leads. Bioorg Med Chem Lett (2009) 0.84
Blood component therapy: Which, when and how much. J Anaesthesiol Clin Pharmacol (2011) 0.82
Urokinase is required for the formation of mactinin, an alpha-actinin fragment that promotes monocyte/macrophage maturation. Biochim Biophys Acta (2002) 0.82
Genetic variation in platinating agent and taxane pathway genes as predictors of outcome and toxicity in advanced non-small-cell lung cancer. Pharmacogenomics (2014) 0.82
Albright's hereditary dystrophy: brain stones. BMJ Case Rep (2014) 0.82
Evaluation of a novel hexavalent humanized anti-IGF-1R antibody and its bivalent parental IgG in diverse cancer cell lines. PLoS One (2012) 0.81
Spectrum of orbital and ocular adnexal lesions: an analysis of 389 cases diagnosed by fine needle aspiration cytology. Diagn Cytopathol (2011) 0.81
Prognostication of diffuse large B-cell lymphoma in the rituximab era. Leuk Lymphoma (2011) 0.81
Evaluation of pharmacological activities and assessment of intraocular penetration of an ayurvedic polyherbal eye drop (Itone™) in experimental models. BMC Complement Altern Med (2013) 0.81
Single and multidose ocular kinetics and stability analysis of extemporaneous formulation of topical voriconazole in humans. Curr Eye Res (2010) 0.80
The microenvironment of AFT024 cells maintains primitive human hematopoiesis by counteracting contact mediated inhibition of proliferation. Cell Commun Adhes (2003) 0.80
Laparoscopic management of gastric angiomyolipoma: case report and review of literature. Surg Laparosc Endosc Percutan Tech (2012) 0.80
Morphine promotes renal pathology in sickle mice. Int J Nephrol Renovasc Dis (2012) 0.80
HRCT evaluation of microtia: A retrospective study. Indian J Radiol Imaging (2012) 0.80
Pneumococcal pyomyositis: report of 2 cases and review of the literature. Clin Infect Dis (2012) 0.79
Predictors of embolic events in pediatric infective endocarditis. Indian Heart J (2012) 0.79
Arthrobacter sp. lipase immobilization for preparation of enantiopure masked beta-amino alcohols. Bioorg Med Chem (2008) 0.79
Chondroblastic osteosarcoma of the temporal region: a diagnostic dilemma. Diagn Cytopathol (2010) 0.78